Status epilepticus in childhood and adolescence (after the neonatal period) with need for admission to critical care

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00016948

Enrollment

240

Registered

2019-07-22

Start date

2019-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G41

Interventions

Group 1: Non-interventional, epidemiological study on pediatric status epilepticus using The German Paediatric Surveillance Unit (ESPED) using a questionnaire to be completed by the treating physicia

Eligibility

Sex/Gender

All

Age

29 Days to 18 Years

Inclusion criteria

Inclusion criteria: Children and adolescents from the 29th day of life to the age of 18 years with a status epilepticus, with need for admission to a pediatric critical care unit of at least 4 hours. Status epilepticus defined as (a) continuous clinical and/or electroencephalographic seizure activity with or without loss of consciousness of 5 minutes duration. or (b) a repeated occurrence of epileptic seizures without any complete recurrence of consciousness in the meantime

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
1. Incidence of pediatric status epilepticus in Germany using The German Paediatric Surveillance Unit (ESPED)-Questionnaire	—

Secondary

Measure	Time frame
2. Description of seizure semiology, duration of the seizure and the underlying etiology (triggering event, associated underlying diseases and description of possible risk groups) 3. Recording of the diagnostics performed 4. Recording of the therapy performed (in addition to medication) 5. Determination of SE-related morbidity at dismissal and mortality each by using The German Paediatric Surveillance Unit (ESPED) questionnaire	—

Measure

Time frame

2. Description of seizure semiology, duration of the seizure and the underlying etiology (triggering event, associated underlying diseases and description of possible risk groups) 3. Recording of the diagnostics performed 4. Recording of the therapy performed (in addition to medication) 5. Determination of SE-related morbidity at dismissal and mortality each by using The German Paediatric Surveillance Unit (ESPED) questionnaire

—

Countries

Germany

Contacts

Public ContactDaniel Ebrahimi-Fakhari

Klinik für Kinder- und Jugendmedizin, Allgemeine Pädiatrie, Universitätsklinikum Münster

daniel.ebrahimi-fakhari@ukmuenster.de0251-83-47762

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026